Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Pathophysiology/Complications

Early-Onset Insulin-Resistant Diabetes in Obese Caucasians Has Features of Typical Type 2 Diabetes, but 3 Decades Earlier

  1. Siobhan McQuaid, MRCPI1,
  2. Donal J. O’Gorman, MSC1,
  3. Obada Yousif, MRCPI1,
  4. Toh Peng Yeow, MRCPI1,
  5. Yusof Rahman, MRCPI1,
  6. Declan Gasparro, BSC1,
  7. Giovanni Pacini, DSC2 and
  8. John J Nolan, FRCPI1
  1. 1Metabolic Research Unit, Department of Endocrinology, St. James’s Hospital, Dublin, Ireland
  2. 2Metabolic Unit, Institute of Biomedical Engineering, National Research Council, Padova, Italy
  1. Address correspondence and reprint requests to Prof. John J. Nolan, Metabolic Research Unit, Department of Endocrinology, St. James’s Hospital, Dublin 8, Ireland. E-mail: jnolan{at}stjames.ie
Diabetes Care 2005 May; 28(5): 1216-1218. https://doi.org/10.2337/diacare.28.5.1216
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Obesity has dramatically increased in Irish adolescents and young adults and is related to changes in physical activity and diet (1,2). Severe obesity is associated with a much earlier presentation of type 2 diabetes (3—6), as noted in Irish Caucasian patients (7). Most studies of early-onset type 2 diabetes have been in minority populations with higher risk of type 2 diabetes than Caucasians (4—6). The potential for diabetes complications in these young individuals has immediate implications for diagnosis and treatment and longer-term implications for public health. We measured insulin resistance, insulin secretion, and a range of cardiovascular risk markers in an obese group of young Irish subjects with type 2 diabetes and compared them with a matched group of obese nondiabetic subjects and a representative group of older subjects with type 2 diabetes. All of the subjects were from the same clinic, and all were matched for obesity and duration of diabetes.

RESEARCH DESIGN AND METHODS

Eleven subjects with early-onset (age <25 years) and 14 subjects with typical-onset (age >40 years) type 2 diabetes were recruited, as well as 13 nondiabetic control subjects who were age and obesity matched to the young type 2 diabetic group. The protocol had ethical approval, and written informed consent was obtained. An oral glucose tolerance test was used to confirm glucose tolerance.

Intravenous glucose tolerance test

An insulin-modified frequently sampled intravenous glucose tolerance test was performed (8,9). Oral hypoglycemic agents were withheld for 7 days before the test. Subjects regularly treated with insulin were given short-acting insulin the night before the study, omitted on the morning of the study. At 8:00 a.m. after an overnight fast, blood samples were taken for glucose, insulin, lipid profile, and soluble cell adhesion markers. Subsequently, a 0.3-g/kg glucose bolus was administered intravenously over 1 min. At 20 min, a 0.05-units/kg insulin bolus (Actrapid; Novo Nordisk, Bagsvaerd, Denmark) was administered intravenously and samples collected until 180 min. Minimal model analysis (8,10) was used to assess first-phase insulin secretion, insulin sensitivity (SI), glucose effectiveness (SG), and the disposition index (9).

Laboratory analysis

Serum insulin and C-peptide were measured by fluoroimmunoassays (Auto-Delfia). Cholesterol and triglycerides were measured using enzymatic methods (Human liquicolor kits; Hitachi Modular). HDL and LDL cholesterol were measured directly with enzymatic methods (Randox direct kits; Hitachi Modular). Plasma glucose was measured using a glucose oxidase method and HbA1c with a Hi-Auto A1c analyzer (Menarini HA 8140). GAD antibodies were measured using a direct radioligand assay (Centrak anti-GAD65; Medipan Diagnostica). Intercellular adhesion molecule, vascular cell adhesion molecule, E-selectin, and P-selectin were measured using monoclonal antibody enzyme-linked immunosorbent assays (R & D Systems). High-sensitivity C-reactive protein was measured using a nephelometric immunoassay (BNII nephelometer; Dade Behring).

RESULTS

Clinical characteristics

The clinical characteristics and metabolic parameters are shown in Table 1. All groups were similarly obese, although the young type 2 diabetic group was taller (P = 0.002) and weighed ∼20 kg more (P = 0.005) than the older type 2 diabetic group. Both diabetic groups had a similar duration of disease of ∼3 years. All subjects were negative for GAD antibodies. All but one (adopted) subject in the young type 2 diabetic group had a history of type 2 diabetes in two generations and at least one first-degree relative. Fifty-four percent of the obese control group and 50% of the older type 2 diabetic group had a history of type 2 diabetes in a first-degree relative. The young type 2 diabetic group was receiving oral hypoglycemic agents; one subject was treated with a combination of metformin and insulin. Three members of the young type 2 diabetic group and three of the control group had acanthosis nigricans, which was not present in the older subjects.

Metabolic variables

Glycemic control was similar between the young type 2 diabetic and older diabetic groups (HbA1c 8.9 and 8.4%, NS). The young type 2 diabetic and young obese groups had fasting hyperinsulinemia, but despite a similar duration of diabetes, the older type 2 diabetic group had significantly lower fasting insulin (P = 0.02).

Fasting lipid profiles were similar in the two diabetic groups with elevated triglycerides and LDL cholesterol in comparison to the young obese control subjects. HDL cholesterol was significantly lower in the young type 2 diabetic group than either the obese control subjects or the older type 2 diabetic group.

All groups were insulin resistant [SI for lean control subjects, age 28 ± 3 years, BMI 23.4 ± 1.2 kg/m2, at this center 7.0 ± 1.3 10−4 min−1/(μU/ml)]. Both diabetic groups were significantly more insulin resistant than the obese nondiabetic group. SG was similar between both diabetic groups and significantly lower than the young obese group. Though severely blunted, first-phase insulin secretion and the disposition index were significantly greater in the young type 2 diabetic than in the older type 2 diabetic group, reflecting a less-advanced loss of β-cell function in the young type 2 diabetic subjects.

Inflammatory and soluble cell adhesion markers

Soluble cell adhesion molecules and high-sensitivity C-reactive protein were elevated in all groups. In the young type 2 diabetic group, intercellular adhesion molecules, vascular cell adhesion molecules, and E-selectin were positively associated with fasting serum insulin (r = 0.84, P = 0.002; r = 0.79, P = 0.007; and r = 0.85, P = 0.002, respectively) and the first-phase insulin secretory response (r = 0.84, P = 0.002; r = 0.77, P = 0.01; and r = 0.86, P = 0.001, respectively). P-selectin was associated with fasting plasma glucose (r = 0.65, P = 0.04).

CONCLUSIONS

Early-onset type 2 diabetes increases the lifelong duration of diabetes and the risk of diabetes-related complications, particularly cardiovascular disease (11,12). Rare monogenic forms of early-onset non–type 1 diabetes, such as maturity-onset diabetes of the young and mitochondrial diabetes, vary in their potential to cause cardiovascular complications but are less aggressive than typical type 2 diabetes. Our young diabetic subjects have classical features of type 2 diabetes and are dyslipidemic in comparison to age-matched obese control subjects, with a reduction in HDL cholesterol and an elevation of LDL cholesterol and triglycerides. Our subjects are more dyslipidemic than a previously reported group of obese 12-year-old children who were shown to have arterial wall stiffness and endothelial dysfunction (13). Soluble cell adhesion markers were similar to, or greater than, other published studies of type 2 diabetic subjects (14—16). High-sensitivity C-reactive protein >5 mg/l (in all groups) is consistent with a markedly increased risk of cardiovascular events (17,18). In conclusion, young Caucasian subjects present with type 2 diabetes exactly the same as typical type 2 diabetes of later onset, characterized by severe obesity, insulin resistance, and loss of first-phase insulin secretion. This cohort has, in addition to these metabolic features, a marked dyslipidemia and evidence of high risk for accelerated cardiovascular complications.

View this table:
  • View inline
  • View popup
Table 1—

Clinical and metabolic characteristics of young obese, young type 2 diabetic, and older type 2 diabetic patients

Acknowledgments

This project was supported by a grant from the Health Research Board, Ireland.

We thank all study volunteers and the nurses of the Metabolic Research Unit and the Diabetes Day Centre of St. James’s Hospital for their assistance with the clinical studies.

Footnotes

  • S.M. and D.J.O contributed equally to this work.

    A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • Accepted January 26, 2005.
    • Received November 16, 2004.
  • DIABETES CARE

References

  1. ↵
    Health Promotion Unit (Ireland): National Health and Lifestyle Surveys. Dublin, Department of Health and Children, 2003
  2. ↵
    Lissau I, Overpeck MD, Ruan WJ, Due P, Holstein BE, Hediger ML, the HBSC Obesity Working Group: Body mass index and overweight in adolescents in 13 European countries, Israel, and the United States. Arch Pediatr Adolesc Med 158:27–33, 2004
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    American Diabetes Association: Type 2 diabetes in children and adolescents. Diabetes Care 23:381–389, 2000
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Fagot-Campagna A, Pettitt DJ, Engelgau MM, Burrows NR, Geiss LS, Valdez R, Valdez R, Beckles GL, Saaddine J, Gregg EW, Williamson DF, Narayan KM. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 136:664–672, 2000
    OpenUrlCrossRefPubMedWeb of Science
  5. Goran MI, Bergman RN, Cruz ML, Watanabe R: Insulin resistance and associated compensatory responses in African-American and Hispanic children. Diabetes Care 25:2184–2190, 2002
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Pinhas-Hamiel O, Standiford D, Hamiel D, Dolan LM, Cohen R, Zeitler PS: The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med 153:1063–1067, 1999
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    O’Gorman DJ, Yousif O, O’Donghaile D, Murphy E, Gasparro D, Pacini G, Nolan JS: Early onset type 2 diabetes: severe obesity with classical insulin resistance phenotype (Abstract). Int J Obes 25(Suppl. 2):S97, 2001
    OpenUrl
  8. ↵
    Pacini G, Tonolo G, Sambataro M, Maioli M, Ciccarese M, Brocco E, Avogaro A, Nosadini R: Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin–modified IVGTT. Am J Physiol 274:E592–E599, 1998
  9. ↵
    Ahrén B, Pacini G: Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 150:97–104, 2004
    OpenUrlAbstract
  10. ↵
    Cutfield WS, Bergman RN, Menon RK, Sperling MA: The modified minimal model: application to measurement of insulin sensitivity in children. J Clin Endocrinol Metab70:1644–1650, 1990
    OpenUrl
  11. ↵
    Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA, for the Bogalusa Heart Study: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 338:1650–1656, 1998
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    Steinberger J, Daniels SR: Obesity, insulin resistance, diabetes, and cardiovascular risk in children. Circulation 107:1448–1453, 2003
    OpenUrlFREE Full Text
  13. ↵
    Tounian P, Aggoun Y, Dubern B, Varielle V, Guy-Grand B, Sidi D, Girardet JP, Bonnet D: Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 358:1400–1440, 2001
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A, Taskinen MR: Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 166:387–394. 2003
  15. Bagg W, Ferri C, Desideri G, Gamble G, Ockelford P, Braatvedt GD: The influences of obesity and glycemic control on endothelieal activation in patients with type 2 diabetes. J Clin Endocrinol Metab 86:5491–5497, 2001
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    Targher G, Bonadonna R, Alberiche M, Zenere M, Muggeo M, Bonora E: Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals. Diabetes Care 24:1961–1966, 2001
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Speidl WS, Graf S, Hornykewycz S, Nikfardjam M, Niessber A, Zorn G, Wojta J, Huber K: High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease. Am Heart J 144:449–455, 2002
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Theuma P, Fonesca VA: Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis. Curr Diab Rep 3:248–254, 2003
    OpenUrlPubMed
PreviousNext
Back to top
Diabetes Care: 28 (5)

In this Issue

May 2005, 28(5)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Early-Onset Insulin-Resistant Diabetes in Obese Caucasians Has Features of Typical Type 2 Diabetes, but 3 Decades Earlier
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Early-Onset Insulin-Resistant Diabetes in Obese Caucasians Has Features of Typical Type 2 Diabetes, but 3 Decades Earlier
Siobhan McQuaid, Donal J. O’Gorman, Obada Yousif, Toh Peng Yeow, Yusof Rahman, Declan Gasparro, Giovanni Pacini, John J Nolan
Diabetes Care May 2005, 28 (5) 1216-1218; DOI: 10.2337/diacare.28.5.1216

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Early-Onset Insulin-Resistant Diabetes in Obese Caucasians Has Features of Typical Type 2 Diabetes, but 3 Decades Earlier
Siobhan McQuaid, Donal J. O’Gorman, Obada Yousif, Toh Peng Yeow, Yusof Rahman, Declan Gasparro, Giovanni Pacini, John J Nolan
Diabetes Care May 2005, 28 (5) 1216-1218; DOI: 10.2337/diacare.28.5.1216
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort
  • Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes
  • High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
Show more Pathophysiology/Complications

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.